Estimation of the bicarbonate difference under optimal and real conditions in the neoadjuvant treatment of early breast cancer

Estimation of the bicarbonate difference under optimal and real conditions in the neoadjuvant treatment of early breast cancer - Your time

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00033577

Enrollment

Registered

2024-02-07

Start date

2024-03-01

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

C50.9

Interventions

Group 1: patients with early breast cancer who underwent neoadjuvant chemotherapy at Dept. of Ob/Gyn of University Hospital Ulm.

Eligibility

Sex/Gender

Female

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Patients who receive neoadjuvant treatment of an eBC in the Ulm Women's Clinic during the defined recruitment interval.

Exclusion criteria

Exclusion criteria: The exclusion criteria are recurrence and/or metastatic disease.

Design outcomes

Primary

Measure	Time frame
A questionnaire is used to evaluate the quality of life. Additionally, the time that the patient spent during neoadjuvant period with her treatment (chemotherapy and additional visits) will be recorded in order to discover the potential for optimization.	—

Secondary

Measure	Time frame
The carbon-footprint of the therapy will be calculated based on the time spent in the therapy and other factors.	—

Countries

Germany

Contacts

Public ContactStefan Lukac

Klinik für Frauenheilkunde und Geburtshilfe, Universitätsklinikum Ulm

stefan.lukac@uniklinik-ulm.de+4973150088

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026